High-sensitivity Troponin in Predicting Coronary Artery Disease for Primary Prevention in Indian Population

Narra Lavanya1, Abraham Oomman2

  • 1Consultant Interventional Cardiologist, Department of Cardiology, KIMS Hospital, Kondapur, Hyderabad, Telangana, India, Corresponding Author.

Insights

Elevated high-sensitivity troponin I (hs-cTnI) levels strongly correlate with coronary artery disease (CAD) detected by CT coronary angiogram. This finding supports using hs-cTnI for noninvasive CAD detection and early management.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Medical Imaging

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality globally.
  • Accurate risk assessment for coronary artery disease (CAD) is crucial for timely intervention.
  • High-sensitivity troponin assays offer potential for early detection of myocardial injury.

Purpose of the Study:

  • To correlate high-sensitivity troponin I (hs-cTnI) and QRISK3 cardiovascular risk score with CT coronary angiogram (CT-CAG) findings.
  • To assess the accuracy of noninvasive methods for detecting or excluding CAD.
  • To evaluate the utility of hs-cTnI as a biomarker for CAD.

Main Methods:

  • A study of 100 patients presenting with chest pain.
  • Measurement of hs-cTnI levels and calculation of QRISK3 scores.
  • Performance of CT coronary angiogram (CT-CAG) to diagnose significant CAD ( >50% stenosis).

Main Results:

  • No statistical correlation was found between QRISK3 scores and hs-cTnI levels.
  • Elevated hs-cTnI (>6) was observed in 20% of subjects.
  • A strong correlation was established between elevated hs-cTnI and the presence of CAD on CT-CAG, with 80% of subjects with elevated hs-cTnI having CAD.

Conclusions:

  • Elevated hs-cTnI levels demonstrate a strong correlation with CAD diagnosed via CT-CAG.
  • hs-cTnI shows promise as a noninvasive biomarker for early CAD detection.
  • Early detection of CAD through biomarkers like hs-cTnI can facilitate prompt management and disease progression delay.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
116
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
331
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213